Skip to main content
Biotronik's 3rd-gen injectable cardiac monitor wins FDA clearance

Biotronik has secured clearance from the FDA for its BIOMONITOR III injectable cardiac monitor, which is designed for documenting unexplained syncope or suspected arrhythmias. The device, which is 60% smaller than the earlier version, works with a patient app that enables real-time annotation of patients' symptoms and reports system diagnostics to facilitate patient-provider engagement.

Full Story: